Literature DB >> 30387409

Comparison of the application of artificial ossicles and autologous ossicles in the reconstruction of a damaged ossicular chain.

L Zhao1, J Li2, S Gong1.   

Abstract

OBJECTIVE: To evaluate the therapeutic effect that the titanium partial ossicular reconstruction prosthesis and autologous ossicles have on hearing loss after reconstruction of a damaged ossicular chain.
METHODS: Forty-two medical records of treatments carried out from 2013 to 2015 for ossicular chain damage with facial nerve paralysis due to temporal bone fractures were reviewed. The study assessed: causes of damage, pre-operative pure tone audiometry findings, types of intra-operative ossicular chain damage, intra-operative ossicular chain repair methods (titanium partial ossicular reconstruction prosthesis or autologous ossicles) and post-operative pure tone audiometry results.
RESULTS: The titanium partial ossicular reconstruction prosthesis was used in 26 cases; the average air-bone gap was 32.3 ± 5.3 dB pre-operatively and 12.8 ± 5.3 dB post-operatively. Autologous ossicles were used in 16 cases; the average air-bone gap was 33.4 ± 4.5 dB pre-operatively and 17.8 ± 7.8 dB post-operatively.
CONCLUSION: Ossicular chain reconstruction is an effective way of improving hearing in patients with ossicular chain damage. The results suggest that repair with either the titanium partial ossicular reconstruction prosthesis or autologous ossicles can improve hearing following ossicular chain injury with facial nerve paralysis caused by a temporal bone fracture.

Entities:  

Keywords:  Hearing Loss; PORP; Titanium

Mesh:

Substances:

Year:  2018        PMID: 30387409     DOI: 10.1017/S0022215118001627

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  1 in total

1.  FDA MAUDE database analysis of titanium middle ear prosthesis.

Authors:  Jaclyn Carey; Sairisheel Gabbireddy; Luke Mammen; Gianna Rosamilia; Varun Patel; David Foyt; Steven Parnes
Journal:  J Otol       Date:  2021-08-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.